Complete Remission of Refractory, Ulcerated, Primary Cutaneous CD30+ Anaplastic Large Cell Lymphoma Following Brentuximab Vedotin Therapy
Nikolaos Patsinakidis, Alexander Kreuter, Rose K.C. Moritz, Markus Stücker, Peter Altmeyer, Katrin Möllenhoff
DOI: 10.2340/00015555-1874
Abstract
Abstract is missing (Short Communication)
Significance
Supplementary content
Comments
